Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
52,451,093
-
Share change
-
+629,370
-
Total reported value
-
$2,108,521,648
-
Price per share
-
$40.20
-
Number of holders
-
192
-
Value change
-
+$26,285,233
-
Number of buys
-
87
-
Number of sells
-
90
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2016
As of 31 Dec 2016,
HAEMONETICS CORP - Common Stock (HAE) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,451,093 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, VICTORY CAPITAL MANAGEMENT INC, FULLER & THALER ASSET MANAGEMENT, INC., Neuberger Berman Group LLC, DIMENSIONAL FUND ADVISORS LP, and BlackRock Institutional Trust Company, N.A..
This page lists
192
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.